Information Provided By: 
Fly News Breaks for September 3, 2019
HCP
Sep 3, 2019 | 06:23 EDT
Barclays analyst Steve Valiquette started HCP with an Overweight rating and $37 price target. Within U.S. Health Care Services, the analyst sees the greatest near-term growth opportunities in life sciences and medical office buildings in key regions of the U.S. Among large diversified healthcare real estate investment trust, HCP has the greatest leverage to this while waiting for a turnaround in its senior housing assets, Valiquette tells investors in a research note.
News For HCP From the Last 2 Days
HCP
Apr 17, 2024 | 05:15 EDT
